Altre lingue Catalent, Inc.

Azioni

CTLT

US1488061029

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 17/04/2024			Variaz. 5gg	Var. 1 gen.
55,96 ^USD	+0,32%		-1,86%	+24,55%

12/04	CATALENT, INC. : Zacks Investment Research rivede la raccomandazione che passa a Sell	ZM
08/04	Aggiornamento settoriale: i titoli del settore sanitario diminuiscono nel tardo pomeriggio	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)	02:20
Sector Update: Health Care Stocks Decline Late Afternoon	08/04
Sector Update: Health Care Stocks Flat to Higher Premarket Monday	08/04
Novo Nordisk Parent Resubmits US Antirust Application for Catalent Acquisition	08/04
Novo Nordisk parent refiles US application on Catalent deal	08/04
Novo Nordisk owner refiles U.S. application for approval of Catalent deal	08/04
Invenra Inc. Announces Strategic Collaboration with Catalent to Co-Discover Novel Bispecific ADCs	02/04
Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer	13/03
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, ZFOX	12/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT	12/03
Novo Nordisk hopes to launch experimental obesity drug this decade	08/03
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment	07/03
Novo Nordisk présente de nouveaux traitements de l'obésité et fait le point sur le Wegovy	07/03
European stocks hover near record highs at start of busy week	04/03
Catalent : Change in Certifying Accountants - Form 8-K	01/03
Catalent : Publishes Fifth Annual Corporate Responsibility Report	01/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT	24/02
CATALENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalent, Inc. - CTLT	16/02
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, AXNX, BATL, APA	16/02
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT	16/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Catalent, Inc.

Azioni

CTLT

US1488061029

Altre lingue

Filtri